Provided by Tiger Fintech (Singapore) Pte. Ltd.

TuHURA Biosciences, Inc.

3.90
+0.0000
Volume:25.43K
Turnover:98.09K
Market Cap:170.35M
PE:-3.21
High:3.95
Open:3.89
Low:3.76
Close:3.90
Loading ...
Oct 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 25, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Oct 25, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Oct 21, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Oct 04, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Sep 25, 2024

Major Issues Report

Form 8-K - Current report
Sep 25, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 24, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 19, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Sep 18, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations